Alexander Rives is an entrepreneur, investor, and computer scientist, who is the founder and Chief Executive Officer of EvolutionaryScale. EvolutionaryScale is a biotech startup. They developed a transformers-based AI model similar to OpenAI’s GPT-4 and Google’s Bard, but their model is specialized for predicting the structures of protein molecules. These protein structures are crucial for drug development, pollution cleanup, and alternative chemical manufacturing
Before founding EvolutionaryScale, Rives led Meta AI’s protein-folding team, where his group developed a model capable of predicting protein structures 60 times faster than DeepMind’s AlphaFold.
This article will look into Alexander Rives net worth, education, career, and more.Â
C. C. Wei Net Worth: Salary, Education, and Family Details
Alexander Rives Net worth
Unfortunately, we do not have any information available on Alexander Rives’s net worth. We will update this section, as soon as we come across some credible information.
However, based on his successful track record in the biotech industry and leadership roles, it can be inferred that Alexander Rives likely has substantial personal wealth.
Dario Amodei Net Worth, CEO of Anthropic
Education
Alexander Rives completed his Bachelor of Science (BS) in Philosophy and Biology at Yale University in 2004. He then pursued a Doctor of Philosophy (PhD) in Computer Science at New York University, which he finished in 2023.
Career
Alexander Rives began his professional career as an Associate at Accelerator Life Science Partners in 2005. Concurrently, he was an Affiliate at ARCH Venture Partners, a role he held from 2005 to 2016. In 2005, he also co-founded Fate Therapeutics Inc., where he was involved for 18 years.Â
Rives co-founded Syros Pharmaceuticals in 2009, contributing to the company for 14 years until 2023.
In 2014, he co-founded Kallyope and remained with the company for 9 years until 2023. He also served as a Data Scientist at the Flatiron Institute from October 2014 to September 2016. Rives then joined Facebook AI, initially as a Visiting Scientist from March 2020 to November 2021, and subsequently as a Research Scientist from November 2021 to April 2023.
In 2023, he founded EvolutionaryScale and took on the role of the startup’s CEO and Chief Scientist. This biotech startup aims to predict the structures of unknown proteins and has resulted in a database containing 700 million potential 3D structures
Elizabeth Stone Net Worth – Netflix CTO (Chief Technology Officer)
Latest Updates
EvolutionaryScale raised $40 million in seed financing to scale up its model, which predicts protein structure. As of 2024, the startup’s valuation is estimated at $200 million as of the funding round. The model, 60 times faster than DeepMind’s AlphaFold, aids drug design by identifying drug binding to proteins.
In its first year, EvolutionaryScale projects to spend $38 million, with $16 million allocated to computing power. These costs are expected to increase to $161 million in the second year and $278 million in the third year.Â
Harvey C. Jones Net Worth – Member of Nvidia’s Board of Directors
FREQUENTLY ASKED QUESTIONS
What is EvolutionaryScale?
EvolutionaryScale is a biotech startup that aims to predict the structures of unknown proteins. It has resulted in a database containing 700 million potential 3D structures.
Who is Alexander Rives?
Alexander Rives is an entrepreneur, investor, and computer scientist, who is the founder, Chief Executive Officer, and Chief Scientist of EvolutionaryScale, a biotech startup.
